Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,050 GBX | -0.87% | +0.52% | +13.68% |
05-03 | Angle shares up on assay development deal with AstraZeneca | AN |
05-03 | Angle shares up on assay development deal with AstraZenaca | AN |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
850.6 DKK | -2.58% | -4.06% | 556B | ||
217.3 CHF | +1.49% | -1.67% | 189B | ||
91.3 EUR | -0.65% | +0.08% | 123B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.68% | 235B | |
+26.08% | 681B | |
+21.85% | 556B | |
-4.77% | 361B | |
+16.97% | 325B | |
+5.69% | 285B | |
+3.65% | 199B | |
-11.12% | 189B | |
-3.40% | 157B | |
+8.08% | 149B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca : Novo Nordisk hires AstraZeneca executive to revive struggling biopharma unit